Guan Cuizhong, Shen Hua, Dong Shiyong, Zhan Yuhua, Yang Jie, Zhang Qiu, Wang Rong
Tsinghua University Library, Tsinghua University, Beijing, China.
Department of Adult Cardiac Surgery, The Sixth Medical Centre of PLA General Hospital, Beijing, China.
Front Cardiovasc Med. 2023 Mar 10;10:1048903. doi: 10.3389/fcvm.2023.1048903. eCollection 2023.
Using bibliometric method to analyze the research status and development trend of extracorporeal membrane oxygenation (ECMO), we aim to provide clinicians, scientists, and stakeholders with the most up-to-date and comprehensive overview of ECMO research.
Using Excel and VOSviewer, the literature on ECMO was systematically analyzed regarding publication trends, journal source, foundation, countries, institutions, core authors, research hotspots, and market distribution.
There were five important time nodes in the research process of ECMO, including the success of the first ECMO operation, the establishment of ELSO, and the outbreak of influenza A/H1N1 and COVID-19. The R&D centers of ECMO were the United States, Germany, Japan, and Italy, and the attention to ECMO was gradually increasing in China. The products most used in the literature were from Maquet, Medtronic, and LivaNova. Medicine enterprises attached great importance to the funding of ECMO research. In recent years, the literature has mainly focused on the following aspects: the treatment of ARDS, the prevention of coagulation system-related complications, the application in neonatal and pediatric patients, mechanical circulatory support for cardiogenic shock, and ECPR and ECMO during the COVID-19 pandemic.
The frequent epidemic occurrence of viral pneumonia and the technical advancement of ECMO in recent years have caused an increase in clinical applications. The hot spots of ECMO research are shown in the treatment of ARDS, mechanical circulatory support for cardiogenic shock, and the application during the COVID-19 pandemic.
采用文献计量学方法分析体外膜肺氧合(ECMO)的研究现状和发展趋势,旨在为临床医生、科研人员及相关利益者提供关于ECMO研究的最新且全面的概述。
利用Excel和VOSviewer,对ECMO相关文献的发表趋势、期刊来源、基金、国家、机构、核心作者、研究热点及市场分布进行系统分析。
ECMO研究过程中有五个重要时间节点,包括首例ECMO手术成功、体外生命支持组织(ELSO)成立以及甲型H1N1流感和新型冠状病毒肺炎(COVID-19)疫情爆发。ECMO的研发中心为美国、德国、日本和意大利,中国对ECMO的关注度在逐渐增加。文献中使用最多的产品来自迈柯唯(Maquet)、美敦力(Medtronic)和索林集团(LivaNova)。医药企业高度重视对ECMO研究的资助。近年来,文献主要集中在以下方面:急性呼吸窘迫综合征(ARDS)的治疗、凝血系统相关并发症的预防、在新生儿和儿科患者中的应用、心源性休克的机械循环支持以及COVID-19大流行期间的体外心肺复苏(ECPR)和ECMO。
近年来病毒性肺炎的频繁流行以及ECMO技术的进步导致其临床应用增加。ECMO研究热点体现在ARDS的治疗、心源性休克的机械循环支持以及COVID-19大流行期间的应用。